NCT01685671View on ClinicalTrials.gov

Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 26, 2012

Primary Completion Date

December 25, 2012

Study Completion Date

January 15, 2013

Conditions
Anemia
Interventions
DRUG

NESP 60μg

Administrated NESP 60μg once subcutaneously

DRUG

CKD-11101 60μg

Administrated CKD-11101 60μg once subcutaneously

Trial Locations (1)

Unknown

Seoul national university hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT01685671 - Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers | Biotech Hunter | Biotech Hunter